ARCHIVES

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

IOM Report: Nationwide Crisis Facing Cancer Care

September 13, 2013

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005

In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building

October 22, 1999

DCT Board Approves Drug Development Recompetition

November 30, 1990

Guest Editorial by Robert Cook-Deegan: Myriad Case Ruling Likely to Concur With DOJ Arguments

April 19, 2013

New Regimens May Benefit Multiple Myeloma Patients

January 28, 2005